11 – 19 of 19
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2002
-
Mark
Time dependence of the activity concentration ratio of red marrow to blood and implications for red marrow dosimetry.
(
- Contribution to journal › Article
-
Mark
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy. Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates.
(
- Contribution to journal › Article
-
Mark
Single tumor cell uptake and dosimetry of technetium-99m Fab ' anti-CD22 in low-grade B-cell lymphoma
(
- Contribution to journal › Article
- 2001
-
Mark
Durable response to 90-yttrium-Epratuzumab (hLL2) in B-cell lymphoma failing chemotherapy by using dose-fractionation schedule
(
- Contribution to journal › Article
-
Mark
Registration of emission and transmission whole-body scintillation-camera images
(
- Contribution to journal › Article
-
Mark
Distribution of iodine 125-labeled alpha1-microglobulin in rats after intravenous injection
(
- Contribution to journal › Article
- 2000
-
Mark
Carbohydrate groups of alpha1-microglobulin are important for secretion and tissue localization but not for immunological properties
(
- Contribution to journal › Article
- 1999
-
Mark
Radioimmunotherapy using 131I-labeled anti-CD22 monoclonal antibody (LL2) in patients with previously treated B-cell lymphomas
(
- Contribution to journal › Article
- 1987
-
Mark
Scintigraphic method to quantify the passage from brain parenchyma to the deep cervical lymph nodes in rats
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »